2021/05/31

Shionogi Announces Corporate Reorganization and Personnel Reassignment

OSAKA, Japan, May 31, 2021 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that Shionogi will implement the following corporate reorganization and personnel reassignment as of July 1, 2021.

 

1. Corporate Reorganization (see attached organization chart)

(1)        New establishment of the DX Promotion Division

The DX Promotion Division will be newly established to assume the role of creating healthcare solutions using digital technology, making use of data to support the realization of the solutions, and building IT and security infrastructure. The Digital Intelligence Department of the Corporate Strategy Division will be incorporated into the DX Promotion Division. In addition, the related functions of the Corporate Planning Department of the Corporate Strategy Division and the Data Science Office of the Integrated Disease Care Division will be reorganized into the IT & Digital Solution Department and the Data Science Department under the DX Promotion Division.

 

(2)        Reorganization of the Pharmaceutical Research Division

The Biomarker R&D Department, which has been an independent organization, will be incorporated into the Pharmaceutical Research Division to further strengthen the collaboration between research on disease prevention and treatment and research on diagnosis and biomarkers.

 

(3)        Reorganization of the Pharmaceutical Commercial Division

Under the reorganization of the functions of the Sales Planning Department, the Sales Planning Office, which is responsible for improving, reforming, and supervising the operations of the entire Pharmaceutical Commercial Division, and the Sales Promotion Office, which is responsible for planning and promoting sales activities, including promoting disease strategies through activities for core hospitals centered on university hospitals, will be newly established.

 

(4)        Reorganization of the Integrated Disease Care Division

The Disease Care Strategy Department will be incorporated and integrated into the New Product Planning Department to make the commercial strategy globally consistent from the research phase to the post-marketing phase, thereby further enhancing the comprehensive strategy planning function related to healthcare services. The Disease Care Strategy Office will be established under the New Product Planning Department to take on the planning function for each disease area in Japan.

 

(5)        Reorganization of the Global Business Division

The Global Supply Chain Strategy Department of the Corporate Strategy Division will be under the Global Business Division to strengthen the business collaboration between global business and procurement and supply strategy planning functions.

 

(6)        Reorganization of the Corporate Strategy Division

The Business Development Department of the Global Business Division will be incorporated into the Corporate Strategy Division to more strategically promote collaborative creation with various partners, which is the core activity in our Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)”.

 

(7)        Reorganization of the Administration Division

The Sustainability Management Office of the Corporate Planning Department, Corporate Strategy Division, will be incorporated as the Sustainability Management Department under the Administration Division to promote fair corporate activities and further enhance governance and compliance functions while deepening collaboration with organizations in each Division. Meanwhile, to make the independence of the internal audit function clearer, the Internal Control Department will be directly under the President, independent of all Divisions.

 

 

2.Personnel Reassignments (Effective; July 1, 2021)

New (or continuing) Position

Name

Present Position

DX Promotion Division

Corporate Officer, Senior Vice President, DX Promotion Division and IT & Digital Solution Department

Takeshi Shiota

Corporate Officer, Senior Vice President, Corporate Planning Department

Vice President, Data Science Department

Yoshitake Kitanishi

Senior Director, Data Science Office

Pharmaceutical Research Division

Senior Vice President, Pharmaceutical Research Division and Laboratory for Drug Discovery and Development

Jun Yoshimoto

Senior Vice President, Global Development Division and Clinical Research Department

Vice President, Research Planning Department

Shouko Kan-o

Project Management Department

Vice President, Laboratory for Drug Discovery and Disease Research

Gaku Sakaguchi

Vice President, Biomarker R&D Department

Vice President, Laboratory for Advanced Medicine Research

Takashi Mizukawa

Vice President, Research Planning Department

Vice President, Biomarker R&D Department

Tomoyuki Yukizawa

President, Shionogi Pharmacovigilance Center Co., Ltd.

Drug Development and Regulatory Science Division

Vice President, Clinical Research Department

Takeki Uehara

Drug Development and Regulatory Science Division

Vice President, Pharmacovigilance Department

Masako Kaneto

Vice President, Laboratory for Drug Discovery and Development

CMC R&D Division

Senior Director, CMC Planning Office

Takeshi Sakai

CMC Planning Office

Vice President, API R&D Laboratory

Akira Ino

Vice President, Laboratory for Advanced Medicine Research

Vice President, Formulation R&D Laboratory

Minoru Hasegawa

Vice President, Laboratory for Drug Discovery and Disease Research

Vice President, Analytical R&D Laboratory

Yasunori Aoyama

Vice President, API R&D Laboratory

Pharmaceutical Commercial Division

Senior Director, Sales Planning Office

Wataru Imamura

Sales Planning Department

Senior Director, Sales Promotion Office

Masanori Kuroiwa

Sales Planning Department

Senior Director, Specialty Product Office

Toshiyuki Aoi

Senior Director, Pharmaceutical Promotion Department - Region 5

Senior Director, Pharmaceutical Promotion Department - Region 2

Atsushi Nakamura

Sales Planning Department

Senior Director, Pharmaceutical Promotion Department - Region 4

Masashi Katsumata

President, Shionogi Marketing Solutions Co., Ltd.

Senior Director, Pharmaceutical Promotion Department - Region 5

Kazuya Ishida

Pharmaceutical Promotion Department - Region 6

Senior Director, Pharmaceutical Promotion Department - Region 6

Masao Morishita

Senior Director, Specialty Product Office

Senior Director, Pharmaceutical Promotion Department - Region 7

Souichirou Mitsutake

Sales Planning Department

Integrated Disease Care Division

Senior Director, Disease Care Strategy Office

Yohji Urago

Disease Care Strategy Department

Vice President, Corporate Social Responsibility Department and Office for Children’s Bright Future

Hiroyuki Tanaka

Vice President, Corporate Social Responsibility Department

Senior Director, Drug Information Center

Takashi Fukunaga

Medical Affairs Department

Corporate Quality Assurance Supervisor

Vice President, Quality Assurance Department

Kumiko Numa

Vice President, Analytical R&D Laboratory

Global Business Division

Senior Executive Officer, Global Business Division

Kohji Hanasaki

Senior Executive Officer, Corporate Strategy Division

Corporate Strategy Division

Senior Executive Officer, Corporate Strategy Division

John Keller

Senior Executive Officer, Global Business Division

Vice President, Corporate Planning Department

Susumu Mitsumori

Vice President, Disease Care Strategy Department

Administration Division

Senior Executive Officer, Senior Vice President, Administration Division and Legal Affairs Department

Noriyuki Kishida

Senior Executive Officer, Senior Vice President, Administration Division

Vice President, Sustainability Management Department

Masako Kudou

Senior Director, Sustainability Management Office

Other

Vice President, Internal Control Department

Kenji Matsuo

President, Shionogi Business Partner Co., Ltd.

Japanese group companies

President, Shionogi Pharmacovigilance Center Co., Ltd.

Yuka Niimi

Pharmacovigilance Department

President, Shionogi Marketing Solutions Co., Ltd.

Minoru Mitsuda

Vice President, Commercial Division and Sales Planning Department

President, Shionogi Business Partner Co., Ltd.

Shigeki Fujita

Finance & Accounting Department